Join to View Full Profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-359-8111
Fax+1 626-408-3911
Dr. Yamauchi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Nuclear Medicine, 1983 - 1985
Los Angeles County-Harbor-UCLA Medical CenterFellowship, Nuclear Radiology, 1983 - 1985- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Radiology-Diagnostic, 1981 - 1983
University of ColoradoResidency, Radiology-Diagnostic, 1980 - 1981
Huntington Memorial HospitalInternship, Internal Medicine, 1979 - 1980
Certifications & Licensure
CA State Medical License 1981 - 2027
American Board of Radiology Diagnostic Radiology- American Board of Radiology Nuclear Radiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification Sunrise Ambulatory Care, Allscripts, 2014-2017
- CMS Meaningful Use Stage Stage 2 Certification Allscripts FollowMyHealth, Allscripts, 2014-2017
- CMS Meaningful Use Stage Stage 1 Certification Sunrise Acute Care, Allscripts, 2014-2017
Publications & Presentations
PubMed
- Integration of PSMA-Targeted Theranostics into Multidisciplinary Care for Improved Efficiencies and Patient Care.Phillip H Kuo, Erasmus Kofi Poku, Dave M Yamauchi, Susan H Cha, Maria L Parayno
Journal of Nuclear Medicine Technology. 2025-12-03 - A Prospective First-In-Human Pilot StudyF-DCFPyL Prostate-Specific Membrane Antigen Imaging on the RefleXion X1 Positron Emission Tomography-Computed Tomograpghy Subsy...Bo Liu, Savita Dandapani, Yun Li, Scott Glaser, Helen Chen
Advances in Radiation Oncology. 2025-12-01 - hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer.Jamie Rand, Dave Yamauchi, Shyambabu Chaurasiya, Jianying Zhang, Supriya Deshpande
Frontiers in Oncology. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
